| 1 |
29633523 | Synthetic MUC1 Antitumor Vaccine with Incorporated 2,3-Sialyl-T Carbohydrate Antigen Inducing Strong Immune Responses with Isotype Specificity. | 2018 Apr 6 |
1 |
| 2 |
27272845 | Expression of the Tumor-associated Mucin 1 Epitope Analyzed with the Humanized PankoMab-GEX™ Antibody in Malignant and Normal Tissues of the Head and Neck. | 2016 Jun |
2 |
| 3 |
27380866 | Synthesis and immunological evaluation of MUC1 glycopeptide conjugates bearing N-acetyl modified STn derivatives as anticancer vaccines. | 2016 Jul 26 |
2 |
| 4 |
11839249 | Characterization of an anti-MUC1 monoclonal antibody with potential as a cancer vaccine. | 2001 |
2 |
| 5 |
11206842 | Absence of correlation of MUC1 expression to malignant behavior of renal cell carcinoma in experimental systems. | 2000 |
1 |
| 6 |
10070964 | Human colon adenocarcinomas express a MUC1-associated novel carbohydrate epitope on core mucin glycans defined by a monoclonal antibody (A10) raised against murine Ehrlich tumor cells. | 1999 Mar 1 |
1 |
| 7 |
1569123 | Studies of Muc-1 mucin expression and polarity in the mouse mammary gland demonstrate developmental regulation of Muc-1 glycosylation and establish the hormonal basis for mRNA expression. | 1992 Jan |
2 |